Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

In this Interview News Med talks to Dr. Nidhi Dey about immune checkpoints IDO1 and PDL1 and how they relate to cutaneous leishmaniasis research.

How AI is Changing the Conversation Around Hospital Denials

Tanya Sanderson, RN, BSN, MBA, MHA, CLNC, Sr. Director of Revenue Integrity at XSOLIS Of the many complexities within the healthcare industry, medical necessity determinations

January 9, 2024

Berlin Cures achieves key milestone in BC 007 Phase II Trial for treatment of Long COVID – Biotech Investments

Issuer: Berlin Cures Holding AG / Key word(s): Miscellaneous 23.04.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin,

April 24, 2024

New program helps toddlers develop self-control and healthy eating habits

Two of the best predictors of life-long health and well-being are early childhood self-control skills and healthy eating habits.

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.